Alpha-2 agonists in neuroanesthesia

Seminars in Anesthesia, Perioperative Medicine and Pain

Volumn 23, Issue 3, 2004, Pages 181-191

  Bekker, Alex ^a,d   Jorden, Victor S B ^b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c North Chicago   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; CLONIDINE; DEXMEDETOMIDINE; GUANABENZ ACETATE; GUANFACINE; METHYLDOPA; OXYMETAZOLINE; RECEPTOR SUBTYPE; TIZANIDINE;

ANALGESIA; ANESTHESIA; ANESTHESIA MECHANISM; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN METABOLISM; CARDIOVASCULAR FUNCTION; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG INDICATION; DRUG POTENTIATION; ELECTROENCEPHALOGRAPHY; ENDOCRINE FUNCTION; EVOKED CORTICAL RESPONSE; HEAD INJURY; HUMAN; INTRACRANIAL PRESSURE; KIDNEY FUNCTION; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROSURGERY; PHARMACODYNAMICS; POSTOPERATIVE PAIN; POSTTRAUMATIC COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SEDATION; SPINE SURGERY; TRANQUILIZING ACTIVITY;

EID: 5444263070     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sane.2004.01.010     Document Type: Article

References (87)

1. Scheinin M., Pihlavisis M. Molecular pharmacology of alpha-2 adrenoreceptor agonists. Scholz J., Tonner P.H. Bailliere's best practice & research clinical anesthesiology-alpha-2 adrenoreceptor agonists in anesthesia and intensive care. 2000;247-260 Bailliere Tindall, London
2. Khan Z.P., Ferguson C.N., Jones R.M. Alpha-2 and imidazoline receptor agonists their pharmacology and therapeutic role. Anesthesia. 54:1999;146-165
3. Calzada B.C., De Artinano A.A. Alpha-adrenoreceptor subtypes. Pharmacological Res. 44:2001;195-208
4. Stuhmeier K.B., Mainzer B., Cierpka J., et al. Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology. 85:1996;706-712
5. Hodgson P.S., Liu S.S. New developments in spinal anesthesia. Anesthesiol Clin North Am. 18:2000;235-249
6. Gowing L., Farrell M., Ali R., et al. Alpha 2-adrenergic agonists in opioid withdrawal. Addiction. 97:2002;49-58
7. Oddby-Muhrbeck E., Eksborg S., Bergendahl H.T., et al. Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. Anesthesiology. 96:2002;1109-1114
8. El-Kerdawy H.M., Zalingen E.E., Bovill J.G. The influence of the alpha2-adrenoreceptor agonist, clonidine, on EEG and on the MAC of isoflurane. Eur J Anaesthesiol. 17:2000;105-110
9. Alfonsi P. Postanaesthetic shivering epidemiology, pathophysiology, and approaches to prevention and management. Drugs. 61:2001;2193-2205
10. Marchal J.M., Gomez-Luque A., Martos-Crespo F., et al. Clonidine decreases intraoperative bleeding in middle ear microsurgery. Acta Anaesthesiol Scand. 45:2001;27-33
11. Jalonen J., Hynynen M., Kuitunen A., et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 86:1997;331-345
12. Arain S.R., Ebert T.J. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 95:2002;461-466
13. Kamibayashi T., Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology. 93:2000;1345-1349
14. Berridge C.W., Waterhouse B.D. The locus coeruleus-noradrenergic system modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev. 42:2003;33-84
15. Venn R.M., Grounds R.N. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit patient and clinician perceptions. Br J Anaesth. 87:2001;684-690
16. Maze M., Scarfini C., Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin Oct. 17:2001;881-897
17. Coull J.T. Pharmacological manipulations of the alpha-2 noradrenergic system. Effects on cognition. Drugs Aging. 5:1994;116-126
18. Arnsten A.F., Cai J.X., Goldman-Rakic P.S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects evidence for alpha-2 receptor subtypes. J Neurosci. 8:1988;4287-4298
19. Bernard J.M., Hommeril J.L., Passuti N., et al. Postoperative analgesia by intravenous clonidine. Anesthesiology. 75:1991;577-582
20. Ramsay M.A., Jones C.C., Cancemi M.R., et al. Dexmedetomidine improves postoperative pain management in bariatric surgical patients. Anesthesiology ASA. 2002;. Abstracts: A910
21. Hall J.E., Uhrich T.D., Barney J.A., et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 90:2000;699-705
22. Yaksh T.L., Pogrel J.W., Lee Y.W., et al. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoreceptor agonists. J Pharmacol Exp Ther. 272:1995;207-214
23. Eisenach J.C. Alpha-2 agonists and analgesia. Exp Opin Invest Drugs. 3:1994;1005-1010
24. Fragen R.J., Fitzgerald P.C. Effect of dexmedetomidine on the minimum alveolar concentration of sevoflurane in adults age 55-70 years. J Clin Anesth. 11:1999;466-470
25. Inomata S., Kihara S., Yaguchi Y., et al. Reduction in standard MAC and MAC for intubation after clonidine premedication in children. Br J Anaesth. 85:2000;700-704
26. McCallum J.B., Boban N., Hogan Q., et al. The mechanism of alpha-2 adrenergic inhibition of sympathetic ganglionic transmission. Anesth Analg. 87:1998;503-510
27. Talke P., Chen R., Thomas B., et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 90:2000;834-839
28. Quintin L., Bouilloc X., Butin E., et al. Clonidine for major vascular surgery in hypertensive patients a double-blind, controlled, randomized study. Anesth Analg. 83:1996;687-695
29. Jorden V., Herr D. Characterization and management dexmedetomidine- related hypotension following CABG. Crit Care Med. A621:2003
30. Bekker A., Gold M., Basile J., et al. Hemodynamic and respiratory changes related to the use of dexmedetomidine in patients undergoing awake carotid endarterectomy. Anesthesiol ASA. 2003;. Abstr A136
31. Wijeysundera D.N., Naik J.S., Beattie W.S. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications a meta-analysis. Am J Med. 114:2003;742-749
32. Jarvis D.A., Duncan S.R., Segal I.S., et al. Ventilatory effects of clonidine alone and in the presence of alfentanil, in human volunteers. Anesthesiology. 76:1992;899-905
33. Belleville J.P., Ward D.S., Bloor B.C., et al. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 77:1992;1125-1133
34. Ebert T.J., Hall J.E., Barney J.A., et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 93:2000;382-394
35. Myles P.S., Hunt J.O., Holdgaard H.O., et al. Clonidine and cardiac surgery haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intens Care. 27:1999;137-147
36. Venn R.M., Bryant A., Hall G.M., et al. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine, and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 86:2001;650-656
37. Venn R., Newman J., Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intens Care Med. 29:2003;201-207
38. Bauer J.H. Adrenergic blocking agents and the kidney. J Clin Hypertens. 1:1985;199-221
39. Gellai M. Modulation of vasopressin antidiuretic action by renal alpha-2 receptors. Am J Physiol. 259:1990;F1-F8
40. Busija D.W., Leffler C.W. Postjunctional alpha 2-adrenoceptors in pial arteries of anesthetized newborn pigs. Dev Pharmacol Ther. 10:1987;36-46
41. Ferrari-DiLeo G., Potter L.T. Alpha-adrenoceptors and muscarinic receptors in human pial arteries and microvessels a receptor binding study. J Cereb Blood Flow Metab. 5:1985;458-464
42. Ganjoo P., Farber N.E., Hudetz A., et al. In vivo effects of dexmedetomidine on laser Doppler flow and pial arteriolar diameter. Anesthesiology. 88:1998;429-439
43. Ishiyama T., Tohi S., Iida H., et al. Mechanisms of dexmedetomidine- induced cerebrovascular effects in canine in vivo experiments. Anesth Analg. 81:1995;1208-1215
44. Ayajiki K., Toda N. Isolated bovine cerebral arteries from rostral and codal regions distinct responses to adrenoceptor agonists. Eur J Pharmacol. 191:1990;417-425
45. Asano Y., Koehler R.C., Kawaguchi T., et al. Pial arteriolar constriction to alpha 2-adrenergic agonist dexmedetomidine in the rat. Am J Phys. 272:1997;H2547-H2556
46. Karlsson B.R., Forsman M., Roald O.K., et al. Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg. 71:1991;125-129
47. Zornow M.H., Fleisher J.E., Scheller M.S., et al. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg. 70:1990;624-630
48. Lee H.W., Caldwell J., Dodson B., et al. The effect of clonidine on cerebral blood flow velocity, carbon dioxide cerebral vasoreactivity, and response to increased arterial pressure in human volunteers. Anesthesiology. 87:1997;553-558
49. Zornow M.H., Maze M., Dyck J.B., et al. Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab. 13:1993;350-353
50. Prielipp R.C., Wall M.H., Tobin J.R., et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global blood flow. Anesth Analg. 95:2002;1052-1059
51. Ohata H., Iida H., Dohi S., et al. Intravenous dexmedetomidine inhibits cerebrovascular dilation induced by isoflurane and sevoflurane in dogs. Anesth Analg. 89:1999;370-377
52. Ulrich K., Kuschinsky W. In vivo effects of alpha-adrenoreceptor agonists and antagonists on pial veins of cats. Stroke. 16:1985;880-884
53. McCormick J.M., McCormick P.W., Zabramski J.M., et al. Intracranial pressure reduction by a central alpha-2 adrenoreceptor agonist after subarachnoid hemorrhage. Neurosurgery. 32:1993;974-979
54. Minassian A., Beydon L., Decq P., et al. Changes in cerebral hemodynamics after a single dose of clonidine in severely head-injured patients. Anesth Analg. 84:1997;127-132
55. Favre J.B., Gardaz J.P., Ravussin P. Effect of clonidine on ICP and on the hemodynamic responses to nociceptive stimuli in patients with brain tumors. J Neurosurg Anesth. 7:1995;159-167
56. Zornow M.H., Scheller M.S., Sheehan P.B., et al. Intracranial pressure effects of dexmedetomidine in rabbits. Anesth Analg. 75:1992;232-237
57. Talke P., Tong C., Lee H.W., et al. Effect of dexmedetomidine on lumbar cerebrospinal fluid pressure in humans. Anesth Analg. 85:1997;358-364
58. Globus M.Y.T., Busto R., Dietrich W.D., et al. Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J Cereb Blood Flow Metab. 9:1989;892-896
59. Kuhmonen J., Pokorny J., Miettinen R., et al. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology. 87:1997;371-377
60. Hoffman W.E., Cheng M.A., Thomas C., et al. Clonidine decreases plasma catecholamines and improves neurologic outcome following incomplete ischemia in the rat. Anesth Analg. 73:1991;460-464
61. Hoffman W.E., Kochs E., Werner C., et al. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Anesthesiology. 75:1991;328-332
62. Engelhard K., Werner C., Kaspar S., et al. Effect of the alpha-2 agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology. 96:2002;450-457
63. Huang R., Chen Y., Yu A.C., et al. Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes a possible mechanism for its neuroprotective activity. J Cereb Blood Flow Metab. 20:2000;895-898
64. Laudenbach V., Mantz J., Lagercrantz H., et al. Effects of alpha-2 adrenoceptor agonists on perinatal excitoxic brain injury. Anesthesiology. 96:2002;134-141
65. Bischoff P., Mahlstedt D., Blank I., et al. Quantitative topographical electroencephalographic analysis after intravenous clonidine in healthy male volunteers. Anesth Analg. 86:1998;202-207
66. Miyazaki Y., Adachi T., Kurata J., et al. Dexmedetomidine reduces seizure threshold during enflurane anesthesia in cats. Br J Anesth. 82:1999;935-937
67. Farber N., Poterack K., Schmelling W. Dexmedetomidine and halothane produce similar alterations in electroencephalographic and electromyographic activity in cats. Brain Res. 774:1997;131-141
68. Kirchberger K., Schmitt H., Hummel C., et al. Clonidine- and methohexital-induced epileptiform discharges detected by magnetoencephalography (MEG) in patients with localization-related epilepsies. Epilepsia. 39:1998;1104-1112
69. Mirski M.A., Rossell L.A., McPherson R.W., et al. Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy. Anesthesiology. 81:1994;1422-1428
70. Ard J., Doyle W., Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesth. 15:2003;263-266
71. Bekker A., Kaufman B., Samir H., et al. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg. 92:2001;1251-1253
72. Porkkala T., Jantti V., Hakkinen V., et al. Clonidine does not attenuate median nerve somatosensory evoked potentials during isoflurane anesthesia. J Clin Monit Comput. 14:1998;165-170
73. Bloom M., Beric A., Bekker A. Dexmedetomidine infusion and somatosensory evoked potentials. J Neurosurg Anesthiol. 13:2001;320-322
74. Thornton C., Lucas M.A., Newton D.E.F., et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 2. Auditory and somatosensory evoked potentials. Br J Anaesth. 83:1999;381-386
75. Bai-Han L.I., Lohmann J.S., Schuler H., et al. Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats. Anesth Analg. 96:2003;1155-1160
76. Bekker A., Pryadko A., Bloom M., et al. Monitored anesthesia care using dexmedetomidine for awake craniotomy. J Neurosurg Anesth. 14:2002;346
77. Lotto M., Bahtia S., Ebrahim Z., et al. Successful cognitive testing in patients undergoing awake craniotomy with dexmedetomidine and propofol sedation. Anesthesiol ASA. 2003;. Abstr A-356
78. Bekker A., Basile J., Gold M., et al. Safety and efficacy of dexmedetomidine for sedation in patients undergoing awake carotid endarterectomy. Anesthesiol ASA. 2003;. Abstr A-359
79. Traill R., Gillis R. Clonidine premedication for craniotomy effects on blood pressure and thiopentone dosage. J Neurosurg Anesth. 5:1993;171-177
80. Chadha R., Padmanabhan V., Joseph A., et al. Oral clonidine pretreatment for haemodynamic stability during craniotomy. Anaesth Intens Care. 20:1992;341-344
81. Costello T.G., Cormack J.R. Clonidine premedication decreases hemodynamic responses to pin head-holder application during craniotomy. Anesth Analg. 86:1998;1001-1004
82. Sturaitis M., Kroin J., Swamidoss C.S., et al. Effect of intraoperative dexmedetomidine infusion on hemodynamic stability during brain tumor resection. Anesthesiol ASA. 2002;. Abstr A-310
83. Asgeirsson B., Grande P.O., Nordstrom C.H. A new therapy of post-traumatic brain oedema based on haemodynamic principles for brain volume regulation. Intens Care Med. 20:1994;260-267
84. Eker C., Asgeirsson B., Grande P.O., et al. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med. 26:1998;1881-1886
85. Naredi S., Eden E., Zall S., et al. A standardized neurosurgical/ neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury clinical results. Intens Care Med. 24:1998;446-451
86. Chhangani S., Papadakos P. The use of dexmedetomidine for sedation in patients with traumatic brain injury. Anesthesiol Suppl. 2002;. ASCCA:B20
87. Bernard J.M., Hommeril J.L., Legendre M.P., et al. Spinal or systemic analgesia after extensive spinal surgery comparison between intrathecal morphine and intravenous fentanyl plus clonidine. J Clin Anesth. 5:1993;231-236